| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.3 |